Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	12.03	119.99	107.10
Graham Fair Price	5.54	11.64	11.03
PEG	318.10	10.84	2.59
Price/Book	3.39	6.27	6.06
Price/Cash Flow	-12.35	129.67	147.93
Prices/Earnings	-2.55	57.06	58.55
Price/Sales	6.10	53.07	50.02
Price/FCF	-12.35	129.67	147.93
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.86	0.67	0.65
Operating Margin	-4.49	0.32	0.34
ROA	3.69	0.02	0.02
ROE	0.03	0.03	6.09
ROIC	0.03	0.03	-12.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	0.17	-61.82
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.55	-0.04	-91.81
EPS QOQ	0.23	0.05	-76.69
FCF QOQ	-0.08	0.21	174.87
Revenue QOQ	0.03	< 0.005	-99.43
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	3.64
Days Sales Outstanding (DSO)	38.26	39.51	3.27
Inventory Turnover	51500173.00	49690844.00	-3.51
Debt/Capitalization	< 0.005	< 0.005	3.59
Quick Ratio	1.89	1.33	-29.51
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	14.45	14.81	2.47
Cash	3.75	2.79	-25.44
Capex	< 0.005	-0.02	-138.97
Free Cash Flow	0.59	0.72	20.86
Revenue	1.75	1.75	-0.15
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.05	1.49	-27.25
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.68	-3.61	22.92
Naive Interpretation	Member

06 - Financial Health · Weak

Rating